LC Walter, D Bertenthal, K Lindquist, BR Konety - Jama, 2006 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Add to CiteULike Add to Connotea Add to ... Cited by 76 - Related articles - BL Direct - All 5 versions
- ►clinchem.org T Vener, C Derecho, J Baden, H Wang, Y … - Clinical …, 2008 - Am Assoc Clin Chem 1 Veridex LLC, a Johnson & Johnson company, Warren, NJ; 2 Arkansas Urology, Little
Rock, AR; 3 Mayo Validation Support Services, Rochester, MN; 4 Pacific Rim Pathology Medical
Corporation, San Diego, CA; 5 Medical University of Innsbruck, Department of Urology, ... Cited by 21 - Related articles - BL Direct - All 5 versions
CL Amling - Current treatment options in oncology, 2006 - Springer Introduction When the prostate-specific antigen (PSA) test was approved by the US Food and
Drug Administration in 1986 to monitor disease status in patients with prostate cancer, it was
not considered specific enough to be used as a screening test. However, in the early ... Cited by 18 - Related articles - All 2 versions
FF SA - International Journal of Cancer - interscience.wiley.com Both benign and malignant prostate diseases elevate total prostate-specific antigen (tPSA), and
the incidence of benign disease increases markedly with age. There is evidence, however, that
free-to-total PSA ratio (%fPSA) and human kallikrein 2 (hK2) more closely reflect the ... Cited by 15 - Related articles - BL Direct - All 3 versions
VN Giri, J Beebe-Dimmer, M Buyyounouski, A Konski, … - The Journal of Urology, 2007 - Elsevier A total of 609 men were accrued to the Prostate Cancer Risk Assessment Program as of the end
of June 2006, of whom 61.2% were black. Of all participants 19% underwent prostate
biopsies. The prostate cancer incidence was 9.0%, more than 90% of prostate cancers ... Cited by 10 - Related articles - All 18 versions
PR Slev, SL La ulu, WL Roberts - American Journal of Clinical …, 2008 - members.medscape.com Serum prostate-specific antigen (PSA) assays differ in calibration and response to different PSA
forms. We examined intermethod differences in total PSA (tPSA) and free PSA (fPSA)
measurements. We tested 157 samples with tPSA concentrations of 2 to 10 ng/ mL (2-10 ... Cited by 4 - Related articles - BL Direct - All 10 versions
AV Mitra, EK Bancroft, RA Eeles… - BJU international, 2007 - impact-study.co.uk The scope of this review does not cover those men with Afro-Caribbean ancestry; it focuses instead
on studies primarily of men with a positive family history. We aim to give a brief overview of current
screening practices and highlight the genetic evidence for prostate cancer. A review of ... Cited by 4 - Related articles - View as HTML - BL Direct - All 6 versions
- ►nih.gov J Lane, J Howson, JL Donovan, JR Goepel, DJ … - British Medical Journal, 2007 - bmj.com You are seeing this message because your web browser does not support basic web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Objective To investigate the feasibility of testing for ... Cited by 4 - Related articles - BL Direct - All 8 versions
AC Webster, G Wong, JC Craig, JR … - American Journal of …, 2008 - interscience.wiley.com Kidney transplant recipients are at higher risk of cancer at most sites, and cancer after transplantation
causes considerable morbidity and mortality. To optimize long-term patient outcomes, clinicians
balance the prospect of graft failure and dialysis, with competing risks of diabetes, ... Cited by 3 - Related articles - All 4 versions
